Neurogene (NGNE) Change in Acquisitions & Divestments (2014 - 2026)

Neurogene's Change in Acquisitions & Divestments history runs 10 years deep, the most recent figure standing at $130.0 million for Q1 2026.

• Quarterly Change in Acquisitions & Divestments rose 190.83% year-over-year to $130.0 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $370.0 million (up 317.14% YoY) and the FY2025 annual result came in at $284.7 million, up 284.73% from the prior year.
• Change in Acquisitions & Divestments was $130.0 million for Q1 2026 at Neurogene, up from $72.5 million in the prior quarter.
• Across five years, Change in Acquisitions & Divestments topped out at $130.0 million in Q1 2026 and bottomed at -$15.0 million in Q4 2022.
• A 5-year average of $41.1 million and a median of $24.8 million in 2024 frame the typical range for Change in Acquisitions & Divestments.
• Peak annual rise in Change in Acquisitions & Divestments reached 1037.14% in 2025, while the deepest fall reached 49.0% in 2025.
• Neurogene's Change in Acquisitions & Divestments stood at -$15.0 million in 2022, then surged by 133.33% to $5.0 million in 2023, then surged by 215.0% to $15.8 million in 2024, then jumped by 360.32% to $72.5 million in 2025, then surged by 79.31% to $130.0 million in 2026.
• Business Quant data shows NGNE's Change in Acquisitions & Divestments at $130.0 million in Q1 2026, $72.5 million in Q4 2025, and $99.5 million in Q3 2025.